Home > M&A deals 2014 > OnCore Biopharma, Inc. acquires Enantigen Therapeutics, Inc.
Add-on Acquistion · Life Science · October 2014

OnCore Biopharma, Inc. acquires Enantigen Therapeutics, Inc.

On October 1, 2014, OnCore Biopharma, Inc. acquired Enantigen Therapeutics, Inc., a life science company in Pennsylvania, United States.

Deal at a glance

AnnouncedOctober 1, 2014 TypeAdd-on Acquistion TargetEnantigen Therapeutics, Inc. Buyer OnCore Biopharma, Inc. SectorLife Science LocationPennsylvania, United States ValueNot disclosed

Target company

Enantigen Therapeutics, Inc.
Pennsylvania, United States
Life Sciencesector
-founded
Activestatus
View the company profile →

Buyer

OnCore Biopharma, Inc.
Company · 1 deal on record
  • 1st transaction in life science
  • 1st transaction in United States
1deals, all time
1in this sector
2014latest

Members only

Contact details at the buyers and sellers
The full deal history of every party
Co-investors and the other advisors on this deal
Deal value and revenue or EBITDA multiples

Related deals

Orbus Therapeutics, Inc.Same sector and country · Oct 2026
ArtesRx LLCSame sector and country · Aug 2026
Firefly Bio, Inc.Same sector and country · Jul 2026

Questions about this deal

Who acquired Enantigen Therapeutics, Inc.?OnCore Biopharma, Inc. acquired Enantigen Therapeutics, Inc. on October 1, 2014.

What type of deal was it?It was a add-on acquistion in the life science sector in 2014.

See the full picture on AcquityDataContacts, full deal histories, co-investors and deal values. Free for a day with your Google account, no card needed.
Try it free
Data updated daily on AcquityData (Acquity Data).